Live Breaking News & Updates on Both Covaxin

Stay updated with breaking news from Both covaxin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Coronavirus | Criticism of vaccine approval continues


Coronavirus | Criticism of vaccine approval continues
Updated:
Updated:
All India People’s Science Network condemns the “hasty regulatory approval”
Share Article
All India People’s Science Network condemns the “hasty regulatory approval”
Joining the criticism of the government’s green light to COVID-19 vaccines, the All India People’s Science Network (AIPSN), a federation of popular science movements across the country, condemned the “hasty regulatory approval.”
In a statement, the AIPSN said that while it lauded the efforts of Indian scientists in developing indigenous vaccines in less than a year, the government and the Central Drugs and Standards Control Organisation (CDSCO) had “.. seriously damaged these hopes, and also undermined confidence in Covaxin and other vaccines against Covid-19, in particular concerning Covaxin, due to lack of evidence and unsatisfactory scientific basis, non-transparency and concerns around possi ....

United Kingdom , Vineeta Bal , India People Science Network , Indian Institute Of Science Education , Expert Committee , Health Ministry , Standards Control Organisation , All India People , Science Network , Central Drugs , Bharat Biotech , Subject Expert Committee , Both Covaxin , Indian Institute , Science Education , ஒன்றுபட்டது கிஂக்டம் , வினீட்டா பால் , இந்தியா மக்கள் அறிவியல் வலைப்பின்னல் , இந்தியன் நிறுவனம் ஆஃப் அறிவியல் கல்வி , நிபுணர் குழு , ஆரோக்கியம் அமைச்சகம் , தரநிலைகள் கட்டுப்பாடு ஆர்கநைஸேஶந் , அனைத்தும் இந்தியா மக்கள் , அறிவியல் வலைப்பின்னல் , மைய மருந்துகள் , பாரத் பயோடெக் ,